Henry Schein, Inc. (HSIC) Downgraded by Zacks Investment Research to Sell

Adjust Comment Print

Henry Schein, Inc. (NASDAQ:HSIC)'s RSI (Relative Strength Index) is 22.32.

A stock rating usually tells investors how well a stock's market value relates to what analysts think is a fair value for the stock, based on an independent evaluation of the company. Thrivent Financial For Lutherans now owns 2,890 shares of the company's stock worth $491,000 after buying an additional 80 shares in the last quarter. The company reported $1.68 earnings per share for the quarter, topping analysts' consensus estimates of $1.65 by $0.03. Finally, Benjamin F. Edwards & Company Inc. lifted its stake in Henry Schein by 281.8% during the third quarter. Td Asset Management Inc grew its ownership by buying 28,507 shares an increase of 122.1% in the quarter.

October 20 investment analysts at Jefferies Group LLC made no change to the stock rating of "Hold" with a current price target of $89.00. Trust Co. of Vermont boosted its stake in shares of Henry Schein by 56.7% in the 3rd quarter. Institutional investors and hedge funds own 53.07% of the company's stock.

Several brokerages have commented on HSIC.

On November 7 Leerink Swann kept the company rating at "Market Perform" targeting a price of $77.00. Stifel Nicolaus reduced their target price on Henry Schein from $89.00 to $77.00 and set a "hold" rating for the company in a research note on Tuesday, November 7th. Northcoast Research upgraded shares of Henry Schein from a "neutral" rating to a "buy" rating and set a $109.00 target price on the stock in a research note on Monday, August 7th. Finally, TheStreet downgraded shares of Henry Schein from a "b" rating to a "c+" rating in a research report on Monday, November 6th. The company operates in the Healthcare sector with a market capitalization of 10.93 Million. Henry Schein presently has an average rating of "Hold" and a consensus price target of $89.88.

Active Stocks Getting Hammered: Express Scripts Holding Company (NASDAQ:ESRX)
Baupost Group LLC MA acquired a new stake in shares of Express Scripts Holding in the first quarter valued at about $80,978,000. Shares of Express Scripts Holding Company ( NASDAQ ESRX ) traded up $0.83 during midday trading on Tuesday, reaching $60.88.


NTV Asset Management LLC lifted its stake in shares of Henry Schein, Inc. "(HSIC)" was published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this piece on another site, it was illegally copied and republished in violation of USA and global trademark & copyright legislation.

Are Henry Schein, Inc. Henry Schein has a 1 year low of $67.02 and a 1 year high of $93.50.

Henry Schein, Inc. (NASDAQ: HSIC) has grabbed attention from the analysts when it experienced a change of -0.82% in the last trading session to close at $66.50.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Wednesday, November 2nd. The Company's price to free cash flow for trailing twelve months is 0.00. Profit margins are at 4.50% while the operating margin stands at 6.80%. The Higher end of the revenue forecast is $3.34 Billion, while the Lower end of the forecast is $3.06 Billion. Sure, the percentage is encouraging but better times are ahead as looking out over a next 5-year period, analysts expect the company to see its earnings go up by 9.77%, annually. As of quarter end American International Group Inc had bought a total of 23,440 shares growing its stake by 71.5%.

Henry Schein announced that its Board of Directors has initiated a share repurchase program on Monday, September 18th that permits the company to buyback $400.00 million in shares. This repurchase authorization authorizes the company to repurchase up to 6.3% of its shares through open market purchases. The firm owned 3,300 shares of the company's stock after buying an additional 1,650 shares during the quarter. The stock was sold at an average price of $172.51, for a total value of $366,756.26. Following the completion of the sale, the senior vice president now owns 17,841 shares in the company, valued at approximately $3,077,750.91. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. The technology and value-added services segment provides software, technology and other value-added services to healthcare practitioners.

Comments